Clinical Trials
23 trialsA Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors
Henan Cancer Hospital
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Anhui Provincial Hospital
HCC
Anhui Provincial Hospital
CHALNA2
Institut National de la Santé Et de la Recherche Médicale, France
FRI-STC
National Hepatology & Tropical Medicine Research Institute
BIIRTH
Tuen Mun Hospital
LIVERAL
ANRS, Emerging Infectious Diseases
Lipiocis
ANRS, Emerging Infectious Diseases
ETCABIO
University Hospital, Angers
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
CHOC
University Hospital, Angers
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma
Ningbo Medical Center Lihuili Hospital
Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus
Henan Cancer Hospital
Precision Dietary Intervention Improves Postoperative Energy Intake, Nutritional Status, and Recovery in Patients Undergoing Hepatectomy for Liver Cancer: A Randomized Controlled Trial
Anhui Provincial Hospital
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation
Ningbo Medical Center Lihuili Hospital
The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer
Fujian Cancer Hospital
DETECT-HCC
Linkoeping University
MUTHEC
Institut National de la Santé Et de la Recherche Médicale, France
REVISE-HCC
Manchester University NHS Foundation Trust
HCC-MVI-CAD
Chinese Academy of Sciences
A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)
Anhui Provincial Hospital
ProspEXPO
University Hospital, Angers
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Shanghai Public Health Clinical Center